What is the treatment for Trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis

The first-line treatment for trichomoniasis is oral metronidazole 2g as a single dose, with cure rates of approximately 90-95%. 1, 2

First-Line Treatment Options

  • Metronidazole 2g orally in a single dose is the recommended first-line treatment for trichomoniasis in both males and females 1, 2
  • An alternative regimen is metronidazole 500mg orally twice daily for 7 days, which may be considered when medication adherence is not a concern 1, 3
  • Recent evidence suggests that the 7-day regimen may be more effective than single-dose therapy (11% vs 19% treatment failure rates) 4
  • Tinidazole is an FDA-approved alternative that can be used for trichomoniasis treatment 5

Management of Sexual Partners

  • All sexual partners should be treated simultaneously to prevent reinfection 1, 3
  • Patients should abstain from sexual activity until both they and their partners complete treatment and are asymptomatic 6, 3
  • Asymptomatic partners should be treated even if diagnostic testing is negative or not performed, as they may still harbor the infection 2

Follow-Up Recommendations

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment 3
  • If symptoms persist after treatment, consider reinfection or resistant infection 6, 3

Treatment Failure Management Algorithm

  1. For first treatment failure:

    • Re-treat with metronidazole 500mg twice daily for 7 days 3, 1
  2. For second treatment failure:

    • Administer metronidazole 2g once daily for 3-5 days 3
  3. For persistent failure:

    • Consider susceptibility testing of T. vaginalis to metronidazole 7
    • Consult with infectious disease specialist 6
    • Consider tinidazole as an alternative, which may be effective against some metronidazole-resistant strains 8

Important Clinical Considerations

  • Topical metronidazole gel is NOT effective for trichomoniasis (efficacy <50%) and should not be used 3, 1
  • Metronidazole can cause a disulfiram-like reaction when combined with alcohol, which may include nausea, vomiting, flushing, headache, and abdominal cramps 6
  • Patients should be advised to avoid alcohol during treatment and for at least 24 hours after completing metronidazole therapy 6
  • Common side effects include nausea (23%), headache (7%), and vomiting (4%) 4

Special Situations

Pregnancy

  • Metronidazole 2g single dose is recommended for symptomatic pregnant women after the first trimester 3, 6
  • Multiple studies have not demonstrated consistent association between metronidazole use during pregnancy and teratogenic effects 3

Metronidazole Allergy

  • For patients with an immediate-type allergy to metronidazole, desensitization may be required 3
  • Topical therapy with drugs other than nitroimidazoles can be attempted, but cure rates are low (<50%) 3
  • High-dose intravaginal metronidazole combined with miconazole has shown promise in small studies (80% efficacy) but is not standard of care 9

HIV Infection

  • Patients with HIV should receive the same treatment regimen as those without HIV 3, 1

Common Pitfalls and Caveats

  • Failure to treat sexual partners is a common cause of recurrent infection 1, 10
  • Metronidazole resistance is emerging and should be considered in cases of treatment failure 7
  • Trichomoniasis is associated with adverse pregnancy outcomes and increased HIV transmission risk 10
  • Asymptomatic infection is common in both men and women, highlighting the importance of screening high-risk individuals 10

References

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Trichomoniasis in Patients Consuming Alcohol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.